The True Face of the Pyramid; Physical Activity Level and Cardiovascular Risk in Patients With Breast Cancer
Launched by HACETTEPE UNIVERSITY · Feb 15, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "The True Face of the Pyramid," is studying how physical activity affects heart health in women who have survived breast cancer. Cardiovascular disease is a leading cause of death, and this study aims to understand if being more physically active can help reduce the risk of heart problems for these survivors. The researchers believe that regular exercise may not only improve overall health but also lower the chance of dying from heart disease, especially since many breast cancer survivors face this risk years after their treatment.
To participate in the trial, women aged 40 to 80 who are at least 15 months post-surgery and 6 months after completing their active treatment for breast cancer can volunteer. Participants should be able to read and understand the study materials and follow along with the tests. However, individuals with certain health issues, such as active infections, neurological diseases, or serious heart problems, cannot join. Those who take part can expect to engage in activities that will help researchers learn more about the impact of physical activity on heart health and overall well-being after breast cancer treatment.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. To be between the ages of 40-80 years,
- • 2. Volunteering to participate in the research,
- • 3. At least 15 months after breast cancer surgery,
- • 4. 6 months after active breast cancer treatment (ie surgery/chemotherapy)
- • 5. Having no problem in reading and/or understanding the scales and being able to cooperate with the tests.
- Exclusion Criteria:
- • 1. Presence of active infection,
- • 2. Having a neurological disease or other clinical diagnosis that may affect cognitive status,
- • 3. Having musculoskeletal and neurological disease, symptomatic heart disease, previous lung surgery and malignant disease that may affect exercise performance.
- • 4. Presence of unstable hypertension or diabetes mellitus
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, State, Turkey
Patients applied
Trial Officials
Ebru Calik Kutukcu, PhD
Principal Investigator
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported